{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:03:36Z","timestamp":1789718616423,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81302161"],"award-info":[{"award-number":["No. 81302161"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Program of Department of Science and Technology of Sichuan Province","award":["No.2020YJ0450"],"award-info":[{"award-number":["No.2020YJ0450"]}]},{"DOI":"10.13039\/501100009564","name":"Health and Family Planning Commission of Sichuan Province","doi-asserted-by":"publisher","award":["No.150215"],"award-info":[{"award-number":["No.150215"]}],"id":[{"id":"10.13039\/501100009564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017696","name":"Hebei Province Graduate Innovation Funding Project","doi-asserted-by":"publisher","award":["NO.2021-166"],"award-info":[{"award-number":["NO.2021-166"]}],"id":[{"id":"10.13039\/501100017696","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanxi Province Scholarship Program for Science and Technology Activities of Overseas Students","award":["NO.20210001"],"award-info":[{"award-number":["NO.20210001"]}]},{"name":"Shanxi Provincial Key Laboratory of Hepatobiliary and Pancreatic Diseases","award":["Shanxi Provincial Key Laboratory of Hepatobiliary and Pancreatic Diseases"],"award-info":[{"award-number":["Shanxi Provincial Key Laboratory of Hepatobiliary and Pancreatic Diseases"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08826-3","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:05:35Z","timestamp":1787051135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ZMIZ1 promotes aerobic glycolysis and development of hepatocellular carcinoma through inducing NOTCH1-mediated transcription of PYCR1"],"prefix":"10.1186","volume":"24","author":[{"given":"Jiefeng","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"8826_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cld.2022.08.004","volume":"27","author":"P Ganesan","year":"2023","unstructured":"Ganesan P, Kulik LM. Hepatocellular Carcinoma: New Developments. Clin Liver Dis. 2023;27:85\u2013102.","journal-title":"Clin Liver Dis"},{"key":"8826_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400:1345\u201362.","journal-title":"Lancet"},{"key":"8826_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","volume":"42","author":"Y Wang","year":"2023","unstructured":"Wang Y, Deng B. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev. 2023;42:629\u201352.","journal-title":"Cancer Metastasis Rev"},{"key":"8826_CR4","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"8826_CR5","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H, Cao M, Sun D, He S, Yang F, Yan X, Zhang S, Li N, Chen W. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135:584\u201390.","journal-title":"Chin Med J (Engl)"},{"key":"8826_CR6","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jamasurg.2022.7989","volume":"158","author":"ZJ Brown","year":"2023","unstructured":"Brown ZJ, Tsilimigras DI, Ruff SM, Mohseni A, Kamel IR, Cloyd JM, Pawlik TM. Management of Hepatocellular Carcinoma: A Review. JAMA Surg. 2023;158:410\u201320.","journal-title":"JAMA Surg"},{"key":"8826_CR7","doi-asserted-by":"crossref","unstructured":"Pi\u00f1ero F, Dirchwolf M, Pess\u00f4a MG. Biomarkers in hepatocellular carcinoma: diagnosis, prognosis and treatment response assessment. Cells. 2020;9.","DOI":"10.3390\/cells9061370"},{"key":"8826_CR8","doi-asserted-by":"publisher","first-page":"e25040","DOI":"10.1371\/journal.pone.0025040","volume":"6","author":"X Li","year":"2011","unstructured":"Li X, Zhu C, Tu WH, Yang N, Qin H, Sun Z. ZMIZ1 preferably enhances the transcriptional activity of androgen receptor with short polyglutamine tract. PLoS ONE. 2011;6:e25040.","journal-title":"PLoS ONE"},{"key":"8826_CR9","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.immuni.2015.10.007","volume":"43","author":"N Pinnell","year":"2015","unstructured":"Pinnell N, Yan R, Cho HJ, Keeley T, Murai MJ, Liu Y, Alarcon AS, Qin J, Wang Q, Kuick R, et al. The PIAS-like Coactivator Zmiz1 Is a Direct and Selective Cofactor of Notch1 in T Cell Development and Leukemia. Immunity. 2015;43:870\u201383.","journal-title":"Immunity"},{"key":"8826_CR10","doi-asserted-by":"publisher","first-page":"101621","DOI":"10.1016\/j.molmet.2022.101621","volume":"66","author":"TA Alghamdi","year":"2022","unstructured":"Alghamdi TA, Krentz NAJ, Smith N, Spigelman AF, Rajesh V, Jha A, Ferdaoussi M, Suzuki K, Yang J, Manning Fox JE, et al. Zmiz1 is required for mature \u03b2-cell function and mass expansion upon high fat feeding. Mol Metab. 2022;66:101621.","journal-title":"Mol Metab"},{"key":"8826_CR11","doi-asserted-by":"publisher","first-page":"40644","DOI":"10.1038\/srep40644","volume":"7","author":"N Song","year":"2017","unstructured":"Song N, Shin A, Park JW, Kim J, Oh JH. Common risk variants for colorectal cancer: an evaluation of associations with age at cancer onset. Sci Rep. 2017;7:40644.","journal-title":"Sci Rep"},{"key":"8826_CR12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/aje\/kwt258","volume":"179","author":"KM O\u2019Brien","year":"2014","unstructured":"O\u2019Brien KM, Cole SR, Poole C, Bensen JT, Herring AH, Engel LS, Millikan RC. Replication of breast cancer susceptibility loci in whites and African Americans using a Bayesian approach. Am J Epidemiol. 2014;179:382\u201394.","journal-title":"Am J Epidemiol"},{"key":"8826_CR13","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1158\/0008-5472.CAN-12-1389","volume":"73","author":"LA Rakowski","year":"2013","unstructured":"Rakowski LA, Garagiola DD, Li CM, Decker M, Caruso S, Jones M, Kuick R, Cierpicki T, Maillard I, Chiang MY. Convergence of the ZMIZ1 and NOTCH1 pathways at C-MYC in acute T lymphoblastic leukemias. Cancer Res. 2013;73:930\u201341.","journal-title":"Cancer Res"},{"key":"8826_CR14","doi-asserted-by":"publisher","first-page":"13577","DOI":"10.1038\/s41598-024-59882-y","volume":"14","author":"Y Pang","year":"2024","unstructured":"Pang Y, Sun Y, Wu Y, Li J, Qin P, Guo S, Zhou W, Chen J, Wang J. Targeting the ZMIZ1-Notch1 signaling axis for the treatment of tongue squamous cell carcinoma. Sci Rep. 2024;14:13577.","journal-title":"Sci Rep"},{"key":"8826_CR15","doi-asserted-by":"publisher","first-page":"e2206694120","DOI":"10.1073\/pnas.2206694120","volume":"120","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Lu YX, Liu F, Sang L, Shi C, Xie S, Bian W, Yang JC, Yang Z, Qu L, et al. lncRNA BREA2 promotes metastasis by disrupting the WWP2-mediated ubiquitination of Notch1. Proc Natl Acad Sci U S A. 2023;120:e2206694120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8826_CR16","doi-asserted-by":"crossref","unstructured":"Li Z, Jiang Y, Liu J, Fu H, Yang Q, Song W, Li Y. Exosomes from PYCR1 knockdown bone marrow mesenchymal stem inhibits aerobic glycolysis and the growth of bladder cancer cells via regulation of the EGFR\/PI3K\/AKT pathway. Int J Oncol. 2023;63.","DOI":"10.3892\/ijo.2023.5532"},{"key":"8826_CR17","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00109-022-02216-0","volume":"100","author":"H Lomel\u00ed","year":"2022","unstructured":"Lomel\u00ed H. ZMIZ proteins: partners in transcriptional regulation and risk factors for human disease. J Mol Med (Berl). 2022;100:973\u201383.","journal-title":"J Mol Med (Berl)"},{"key":"8826_CR18","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s10565-021-09641-w","volume":"38","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Jin Q, Chang J, Zhao Z, Sun C. Long non-coding RNA ZMIZ1-AS1 promotes osteosarcoma progression by stabilization of ZMIZ1. Cell Biol Toxicol. 2022;38:1013\u201326.","journal-title":"Cell Biol Toxicol"},{"key":"8826_CR19","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1007\/s10528-023-10573-9","volume":"62","author":"M Huang","year":"2024","unstructured":"Huang M, Wang J, Zhang Z, Zuo X. ZMIZ1 Regulates Proliferation, Autophagy and Apoptosis of Colon Cancer Cells by Mediating Ubiquitin-Proteasome Degradation of SIRT1. Biochem Genet. 2024;62:3245\u201359.","journal-title":"Biochem Genet"},{"key":"8826_CR20","doi-asserted-by":"crossref","unstructured":"Zhao W, Rose SF, Blake R, Godicelj A, Cullen AE, Stenning J, Beevors L, Gehrung M, Kumar S, Kishore K et al. ZMIZ1 enhances ER\u03b1-dependent expression of E2F2 in breast cancer. J Mol Endocrinol. 2024;73.","DOI":"10.1530\/JME-23-0133"},{"key":"8826_CR21","doi-asserted-by":"publisher","first-page":"100264","DOI":"10.1016\/j.labinv.2023.100264","volume":"103","author":"J Liu","year":"2023","unstructured":"Liu J, Sun T, Yin L. ZMIZ1 Upregulation of TET3-Mediated Hydroxymethylation Induces M2 Polarization of Kupffer Cells in Hepatocellular Carcinogenesis by Mediating Notch1\/c-Myc Signaling. Lab Invest. 2023;103:100264.","journal-title":"Lab Invest"},{"key":"8826_CR22","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1182\/blood-2018-02-835850","volume":"132","author":"Q Wang","year":"2018","unstructured":"Wang Q, Yan R, Pinnell N, McCarter AC, Oh Y, Liu Y, Sha C, Garber NF, Chen Y, Wu Q, et al. Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development. Blood. 2018;132:1279\u201392.","journal-title":"Blood"},{"key":"8826_CR23","doi-asserted-by":"crossref","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368.","DOI":"10.1126\/science.aaw5473"},{"key":"8826_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, Yi P, Tang L, Pan Q, Rao S, et al. The cancer metabolic reprogramming and immune response. Mol Cancer. 2021;20:28.","journal-title":"Mol Cancer"},{"key":"8826_CR25","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.semcancer.2022.09.007","volume":"86","author":"S Paul","year":"2022","unstructured":"Paul S, Ghosh S, Kumar S. Tumor glycolysis, an essential sweet tooth of tumor cells. Semin Cancer Biol. 2022;86:1216\u201330.","journal-title":"Semin Cancer Biol"},{"key":"8826_CR26","doi-asserted-by":"publisher","first-page":"1242955","DOI":"10.3389\/fphar.2023.1242955","volume":"14","author":"S Li","year":"2023","unstructured":"Li S, Hao L, Hu X. Natural products target glycolysis in liver disease. Front Pharmacol. 2023;14:1242955.","journal-title":"Front Pharmacol"},{"key":"8826_CR27","doi-asserted-by":"publisher","first-page":"18846","DOI":"10.1038\/srep18846","volume":"6","author":"ML Kuo","year":"2016","unstructured":"Kuo ML, Lee MB, Tang M, den Besten W, Hu S, Sweredoski MJ, Hess S, Chou CM, Changou CA, Su M, et al. PYCR1 and PYCR2 Interact and Collaborate with RRM2B to Protect Cells from Overt Oxidative Stress. Sci Rep. 2016;6:18846.","journal-title":"Sci Rep"},{"key":"8826_CR28","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.biopha.2018.12.089","volume":"111","author":"D Wang","year":"2019","unstructured":"Wang D, Wang L, Zhang Y, Yan Z, Liu L, Chen G. PYCR1 promotes the progression of non-small-cell lung cancer under the negative regulation of miR-488. Biomed Pharmacother. 2019;111:588\u201395.","journal-title":"Biomed Pharmacother"},{"key":"8826_CR29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/carcin\/bgx022","volume":"38","author":"J Ding","year":"2017","unstructured":"Ding J, Kuo ML, Su L, Xue L, Luh F, Zhang H, Wang J, Lin TG, Zhang K, Chu P, et al. Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers. Carcinogenesis. 2017;38:519\u201331.","journal-title":"Carcinogenesis"},{"key":"8826_CR30","doi-asserted-by":"publisher","first-page":"101667","DOI":"10.1016\/j.tranon.2023.101667","volume":"32","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zhao X, Wang E, Yang Y, Hu L, Xu H, Zhang B. PYCR1 promotes the malignant progression of lung cancer through the JAK-STAT3 signaling pathway via PRODH-dependent glutamine synthesize. Transl Oncol. 2023;32:101667.","journal-title":"Transl Oncol"},{"key":"8826_CR31","doi-asserted-by":"publisher","first-page":"985613","DOI":"10.3389\/fonc.2022.985613","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Xu J, Bao P, Wei Z, Pan L, Zhou J, Wang W. Survival and clinicopathological significance of PYCR1 expression in cancer: A meta-analysis. Front Oncol. 2022;12:985613.","journal-title":"Front Oncol"},{"key":"8826_CR32","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1007\/s13577-022-00775-5","volume":"35","author":"B Zhou","year":"2022","unstructured":"Zhou B, Mai Z, Ye Y, Song Y, Zhang M, Yang X, Xia W, Qiu X. The role of PYCR1 in inhibiting 5-fluorouracil-induced ferroptosis and apoptosis through SLC25A10 in colorectal cancer. Hum Cell. 2022;35:1900\u201311.","journal-title":"Hum Cell"},{"key":"8826_CR33","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.7150\/jca.61498","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang H, Mao W, Lou W, Jin D, Wu W, Wang D, Kuang T, Rong Y, Xu X, Zhang L. PYCR1: A Potential Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma. J Cancer. 2022;13:1501\u201311.","journal-title":"J Cancer"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08826-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08826-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08826-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:31:53Z","timestamp":1789716713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08826-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8826"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08826-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The experimental protocols were approved by Ethics Committee of Sichuan Academy of Medical Sciences, Sichuan Provincial People\u2019s Hospital. All procedures performed in studies involving human participants were in accordance with the ethical standards of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1197"}}